Validation of a Predictive Algorithm to Determine the Effectiveness of Orthokeratology for Myopia Control

Sponsor
Sun Yat-sen University (Other)
Overall Status
Unknown status
CT.gov ID
NCT04275635
Collaborator
(none)
3,000
1
17.2
174.6

Study Details

Study Description

Brief Summary

This is a prospective study to validate a predictive algorithm for identifying fast progressing myopes.

Condition or Disease Intervention/Treatment Phase
  • Device: Orthokeratology lenses

Detailed Description

Orthokeratology (ortho-K) has been demonstrated to slow myopic progression and reduce axial elongation in young patients, but this treatment is limited by the need for contact lens wear, which is the common cause for keratitis in children, and therefore cautious use is recommended. There is a need to identify the patients that could benefit most from this treatment. In order to do so, we conduct a retrospective study and create a large database (n = 10,000) of de-identified data to train an algorithm for identifying fast progressing myopes. In addition, we will perform a prospective study to validate this predictive algorithm and determine the effectiveness of Orthokeratology among different individual patients in China.

Study Design

Study Type:
Observational
Anticipated Enrollment :
3000 participants
Observational Model:
Case-Only
Time Perspective:
Prospective
Official Title:
Validation of a Predictive Algorithm to Determine the Effectiveness of Orthokeratology for Myopia Control
Actual Study Start Date :
Feb 25, 2020
Anticipated Primary Completion Date :
Mar 1, 2021
Anticipated Study Completion Date :
Aug 1, 2021

Arms and Interventions

Arm Intervention/Treatment
Children with myopia

A total of 3,000 children from Zhongshan Ophthalmic Center is required to undergo ophthalmic examinations and complete questionnaires at baseline and 1yr after wearing Ortho-K.

Device: Orthokeratology lenses
Orthokeratology lenses

Outcome Measures

Primary Outcome Measures

  1. AUROC of the prediction algorithm for identifying fast progressing myopes [1 year]

    Age-specific axial length (AL) changes previously described by Wang et al.(IOVS, 52 (11), 7949-53, 2011) are used as cut-off values to determine whether a child is a fast progressor or not. A child whose AL change falls on or above the cut-off value is considered to be a fast progressor.

Secondary Outcome Measures

  1. Sensitivity and specificity of the prediction algorithm for identifying fast progressing myopes [1 year]

    The investigators will estimate sensitivity and specificity of the predictive algorithm for identifying fast progressing myopes.

  2. Performance of an algorithm for predicting AL [1 year]

    The investigators will use mean absolute error (MAE), R square to evaluate the performance.

  3. Performance of an algorithm for predicting spherical equivalent refractive error [1 year]

    The investigators will use mean absolute error (MAE), R square to evaluate the performance.

Eligibility Criteria

Criteria

Ages Eligible for Study:
8 Years to 15 Years
Sexes Eligible for Study:
All
Inclusion Criteria:
  • -6.0D≤SER≤-0.5D

  • Astigmatism≤2.0D

Exclusion Criteria:
  • Contraindications of wearing Ortho-K.

  • Diagnosis of strabismus, amblyopia and other refractive development of the eye or systemic diseases.

  • Currently involved in other clinical studies.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Zhognshan Ophthalmic Center (Zhujiang New Town Branch), Sun Yat-sen University Guangzhou Guangdong China 510000

Sponsors and Collaborators

  • Sun Yat-sen University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Yingfeng Zheng, Clinical investigator, Sun Yat-sen University
ClinicalTrials.gov Identifier:
NCT04275635
Other Study ID Numbers:
  • 2020KYPJ018
First Posted:
Feb 19, 2020
Last Update Posted:
Mar 16, 2020
Last Verified:
Mar 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 16, 2020